about
Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugsIn Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I MetabolitesPhthalocyanines and tetrapyrazinoporphyrazines with two cationic donuts: high photodynamic activity as a result of rigid spatial arrangement of peripheral substituents.Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cellsStructure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injuryDodecyl Amino Glucoside Enhances Transdermal and Topical Drug Delivery via Reversible Interaction with Skin Barrier Lipids.Tetra(3,4-pyrido)porphyrazines Caught in the Cationic Cage: Toward Nanomolar Active Photosensitizers.Water-soluble non-aggregating zinc phthalocyanine and in vitro studies for photodynamic therapy.Far-red-absorbing cationic phthalocyanine photosensitizers: synthesis and evaluation of the photodynamic anticancer activity and the mode of cell death induction.Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery.Heteroatom-substituted tetra(3,4-pyrido)porphyrazines: a stride toward near-infrared-absorbing macrocyclesDually directional glycosylated phthalocyanines as extracellular red-emitting fluorescent probes
P50
Q28539989-C585D761-E9AC-44A9-A3DC-67727F3EFEDCQ28550205-196245D1-DAEB-4987-9053-37D5BE218995Q30101126-E84C5D99-04F5-471C-BC83-0B464D71BB2AQ34568034-39F0DA9C-F66A-4EA9-9C4B-A5CF51237C90Q35014803-0B94F8A0-B22F-432C-AC85-5267DD0CB938Q35418008-64B9A0DB-BE8E-4103-9404-DCC34789A88DQ36957543-B825D6DC-D63B-40AB-B05C-FD0842F530F3Q38741123-54A73903-EAFF-4D39-9F49-13F0D548FCFBQ42803870-2E6E69CA-4735-4678-B50A-0E98B75A24F8Q42807073-A580D8FF-0DF3-489A-93FF-7D69BB4610BFQ42813321-9DCF2485-F137-4822-A42E-1B0A08027C66Q42831195-BAAE2757-9E55-4E67-BAEE-B2EF5042B890Q46406290-911C7F84-7D0F-4D31-8ADB-26760ED06152Q47988106-26806F2F-78F0-4A95-940E-4E91A7E8FA14Q61396414-34F9B0FF-4057-434A-9710-3A30394C1B81Q96432580-5C97ADC6-AA31-4F15-B707-8A9E3A497D3B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miloslav Macháček
@ast
Miloslav Macháček
@en
Miloslav Macháček
@es
Miloslav Macháček
@nl
type
label
Miloslav Macháček
@ast
Miloslav Macháček
@en
Miloslav Macháček
@es
Miloslav Macháček
@nl
prefLabel
Miloslav Macháček
@ast
Miloslav Macháček
@en
Miloslav Macháček
@es
Miloslav Macháček
@nl
P106
P1153
56360747400
P31
P496
0000-0001-7221-5914